0
Skip to Content
Alexander I. Velasquez
About
Insights
Cryptocurrency
History of Financial Crises
Stock Analysis
Newsletter
CV / Resume
Seeking Alpha
Archive
Alexander I. Velasquez
About
Insights
Cryptocurrency
History of Financial Crises
Stock Analysis
Newsletter
CV / Resume
Seeking Alpha
Archive
About
Folder: Insights
Back
Cryptocurrency
History of Financial Crises
Stock Analysis
Newsletter
CV / Resume
Seeking Alpha
Archive
The Tulip Bubble (1636–1637): The Flower That Fooled Europe
History of Financial Crises, Market Psychology, Investor Education Alexander I. Velasquez 10/13/25 History of Financial Crises, Market Psychology, Investor Education Alexander I. Velasquez 10/13/25

The Tulip Bubble (1636–1637): The Flower That Fooled Europe

In 1637, Dutch traders turned tulips into a national obsession—then lost everything overnight. Discover how the Tulip Bubble became history’s first financial mania and a timeless investing lesson.

Read More
Nintendo: Switch 2 Cycle Sets Up 60%+ Upside
Stock Analysis, Communication Services, Interactive Home Entertainment Alexander I. Velasquez 9/29/25 Stock Analysis, Communication Services, Interactive Home Entertainment Alexander I. Velasquez 9/29/25

Nintendo: Switch 2 Cycle Sets Up 60%+ Upside

Nintendo (OTCMKTS: NTDOY) and their Switch 2 are off to a record start with 6M units sold in seven weeks. My analysis shows why strong IP, digital sales, and upcoming releases could drive 60%+ investor returns by 2029.

Read More
Monster Beverage: Momentum Brewing, But Shares Are Fairly Priced
Stock Analysis, Consumer Staples, Soft Drinks & Non-alcoholic Beverages Alexander I. Velasquez 9/19/25 Stock Analysis, Consumer Staples, Soft Drinks & Non-alcoholic Beverages Alexander I. Velasquez 9/19/25

Monster Beverage: Momentum Brewing, But Shares Are Fairly Priced

Monster Beverage (NASDAQ:MNST) had record Q2 sales and strong balance sheet highlight impressive growth momentum—but with shares trading above intrinsic value, the stock looks fairly priced for now.

Read More
Niagen Bioscience: A Great Company Suffering From Stock Dilution
Stock Analysis, Healthcare, Life Sciences Tools and Services Alexander I. Velasquez 9/8/25 Stock Analysis, Healthcare, Life Sciences Tools and Services Alexander I. Velasquez 9/8/25

Niagen Bioscience: A Great Company Suffering From Stock Dilution

Niagen Bioscience (NASDAQ:NAGE) has a debt-free balance sheet and Q2 beat show momentum—but heavy share dilution and a price ~133% above my DCF give the stock a hold rating.

Read More
Live Nation Entertainment: A DCF-Driven Bear Case
Stock Analysis, Communication Services, Movies and Entertainment Alexander I. Velasquez 6/16/25 Stock Analysis, Communication Services, Movies and Entertainment Alexander I. Velasquez 6/16/25

Live Nation Entertainment: A DCF-Driven Bear Case

Live Nation Enternatinment (NYSE:LYV) looks ~48% overvalued on my DCF; mixed Q1 (revenue −11%) plus DOJ/FTC scrutiny threaten ticketing margins and vertical integration—why I rate LYV a sell.

Read More
Macy's: An Undervalued Hidden Asset Play
Stock Analysis, Consumer, Broadline Retail Alexander I. Velasquez 4/28/25 Stock Analysis, Consumer, Broadline Retail Alexander I. Velasquez 4/28/25

Macy's: An Undervalued Hidden Asset Play

Macy’s (NYSE:M) looks undervalued: my DCF is $18.15 per share, a 0.68 price-to-book hints at mispriced assets, and ~$20.74/share in real estate makes this a classic hidden-asset play.

Read More
Newer Posts
Older Posts

The Fundamental Brief

One email a month. My sharpest market insight for free.

This content is for informational purposes only — not financial advice.

You're in.
The next issue of The Fundamental Brief will land in your inbox soon.

Follow
YouTube
LinkedIn
X (Twitter)

How We Use Cookies:
Privacy Policy

Investor Resources:
Frequently Asked Questions

© 2025 aivelasquez.com.
All rights reserved.

Email:
mailbox@aivelasquez.com